Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coiled-coil domain-containing protein 201 (CCDC201) is a recently annotated human protein expressed predominantly in ovarian tissue and oocytes, with the highest levels in women of reproductive age and minimal expression after menopause. The gene is conserved across mammals and encodes a protein of 187 amino acids containing characteristic coiled-coil domains. Loss-of-function variants, particularly the stop-gain variant p.(Arg162Ter), are associated with a dramatically increased risk of primary ovarian insufficiency and significantly earlier menopause, supporting a key role in female reproductive function. CCDC201 has not been established as a therapeutic target, nor are there any known drug interactions or biomarker applications at present[1][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil domain-containing protein 201 (CCDC201).